The pharmacokinetics of acetanilide and of diphenylhydantoin sodium
- 1 January 1974
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 7 (6), 461-466
- https://doi.org/10.1007/bf00560359
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pharmacokinetics of single and multiple doses of phenytoin in manEuropean Journal of Clinical Pharmacology, 1974
- Identification of 5-(3,4-Dihydroxyphenyl)-5-Phenylhydantoin as a Metabolite of 5,5-DiphenyIhydantoin (Phenytoin) in Rats and ManPharmacology, 1972
- Binding of 5,5-Diphenylhydantoin and Its Major Metabolite to Human and Rat Plasma ProteinsJournal of Pharmaceutical Sciences, 1971
- MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN*Annals of the New York Academy of Sciences, 1971
- PLASMA PROTEIN BINDING, PLASMA CONCENTRATIONS, AND EFFECTS OF DIPHENYLHYDANTOIN IN MAN*Annals of the New York Academy of Sciences, 1971
- Value of blood phenytoin estimation in management of childhood epilepsy.Archives of Disease in Childhood, 1971
- Molecular Aspects of Drug MetabolismActa Pharmacologica et Toxicologica, 1971
- A new metabolite of 5,5-diphenylhydantoin (Dilantin++Dilantin is the Parke-Davis trade name for 5,5-diphenylhydatoin (phenytoin).)Biochemical and Biophysical Research Communications, 1970
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960
- The Relationship between Decreased 5-Hydroxyindole Metabolism and Mental Defect in PhenylketonuriaArchives of Disease in Childhood, 1959